Clinical results of the ID-KLH vaccination with local GM-CSF in patients with follicular lymphomas (published in Nature Med 1999; 5: 1171-1177) summary of the lecture by L. W. Kwak.
作者信息
Schumacher K
出版信息
J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2(Suppl 2):R10-3. doi: 10.1007/BF01470993.
Abstract
摘要
相似文献
1
Clinical results of the ID-KLH vaccination with local GM-CSF in patients with follicular lymphomas (published in Nature Med 1999; 5: 1171-1177) summary of the lecture by L. W. Kwak.
J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2(Suppl 2):R10-3. doi: 10.1007/BF01470993.
2
Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine.
J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2:R14-9. doi: 10.1007/BF01470994.
3
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.
J Clin Oncol. 2009 Jun 20;27(18):3036-43. doi: 10.1200/JCO.2008.19.8903. Epub 2009 May 4.
4
Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
Expert Opin Biol Ther. 2005 Jun;5(6):841-52. doi: 10.1517/14712598.5.6.841.
5
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.
J Clin Oncol. 2014 Jun 10;32(17):1797-803. doi: 10.1200/JCO.2012.43.9273. Epub 2014 May 5.
6
Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.
J Immunol. 2000 May 1;164(9):4797-803. doi: 10.4049/jimmunol.164.9.4797.
7
Immune responses and outcome in follicular lymphoma.
J Clin Oncol. 2014 Jun 10;32(17):1757-9. doi: 10.1200/JCO.2013.53.8439. Epub 2014 May 5.
8
Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience.
J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2:R20-6. doi: 10.1007/BF01470995.
9
Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2(Suppl 2):R27-33. doi: 10.1007/BF01470996.
10
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.
Nat Med. 1999 Oct;5(10):1171-7. doi: 10.1038/13928.
Zotero 插件